InsiderClue
Insiders · Profile

BARRIS PETER J

Director at Groupon · 10% owner at Mirum Pharmaceuticals · 10% owner at Trevi Therapeutics · and 8 more. Filing since 15 Aug 2013. CIK 0001005561

GRPN Groupon, Inc. Director · 12 trades MIRM Mirum Pharmaceuticals, Inc. 10% owner · 1 trade TRVI Trevi Therapeutics, Inc. 10% owner · 1 trade CBIO CRESCENT BIOPHARMA, INC. 10% owner · 4 trades ORKA Oruka Therapeutics, Inc. 10% owner · 1 trade SENS Senseonics Holdings, Inc. 10% owner · 6 trades APPN APPIAN CORP 10% owner · 2 trades RYTM RHYTHM PHARMACEUTICALS, INC. 10% owner · 1 trade ARDX ARDELYX, INC. 10% owner · 10 trades SUPN SUPERNUS PHARMACEUTICALS, INC. 10% owner · 3 trades GYRE GYRE THERAPEUTICS, INC. 10% owner · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
GRPN Groupon, Inc.
26 Dec 2019
Director
Sold, plan not stated
210,124
$490.95K
80.5%
MIRM Mirum Pharmaceuticals, Inc.
22 Jul 2019
10% owner
Bought
450,000
$6.75M
12.0%
TRVI Trevi Therapeutics, Inc.
9 May 2019
10% owner
Bought
2,500,000
$25.00M
129%
CBIO CRESCENT BIOPHARMA, INC.
10 May 2018
10% owner
Sold, plan not stated
9,539
$169.89K
0.2%
ORKA Oruka Therapeutics, Inc.
26 Feb 2018
10% owner
Sold, plan not stated
1,460,209
$731.27K
100%
SENS Senseonics Holdings, Inc.
8 Dec 2017
10% owner
Sold, plan not stated
32,850
$85.20K
100%
SENS Senseonics Holdings, Inc.
7 Dec 2017
10% owner
Sold, plan not stated
12,100
$31.63K
26.9%
SENS Senseonics Holdings, Inc.
6 Dec 2017
10% owner
Sold, plan not stated
94,695
$249.99K
67.8%
APPN APPIAN CORP
27 Nov 2017
10% owner
Sold, plan not stated
569,620
$11.10M
100%
APPN APPIAN CORP
20 Nov 2017
10% owner
Sold, plan not stated
2,820,516
$54.97M
100%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
10% owner
Bought
550,000
$9.35M
12.6%
GRPN Groupon, Inc.
10 Aug 2017
Director
Sold, plan not stated
281,359
$1.12M
100%
GRPN Groupon, Inc.
9 Aug 2017
Director
Sold, plan not stated
281,360
$1.11M
50.0%
GRPN Groupon, Inc.
12 Jun 2017
Director
Sold, plan not stated
281,352
$854.10K
100%
SENS Senseonics Holdings, Inc.
1 Jun 2017
10% owner
Bought
7,092,198
$10.00M
47.9%
GRPN Groupon, Inc.
2 Mar 2017
Director
Sold, plan not stated
75,000
$313.91K
100%
GRPN Groupon, Inc.
1 Mar 2017
Director
Sold, plan not stated
112,386
$473.52K
60.0%
GRPN Groupon, Inc.
28 Feb 2017
Director
Sold, plan not stated
93,968
$399.86K
33.4%
GRPN Groupon, Inc.
12 Aug 2016
Director
Sold, plan not stated
730,349
$4.15M
100%
ARDX ARDELYX, INC.
18 Jul 2016
10% owner
Bought
763,651
$6.67M
40.2%
ARDX ARDELYX, INC.
18 Jul 2016
10% owner
Bought
763,650
$6.67M
9.6%
ARDX ARDELYX, INC.
18 Jul 2016
10% owner
Bought
763,650
$6.67M
40.2%
GRPN Groupon, Inc.
10 Jun 2016
Director
Sold, plan not stated
358,382
$1.15M
100%
GRPN Groupon, Inc.
9 Jun 2016
Director
Sold, plan not stated
281,663
$918.36K
44.0%
SENS Senseonics Holdings, Inc.
23 Mar 2016
10% owner
Bought
1,578,947
$4.50M
11.9%
SENS Senseonics Holdings, Inc.
23 Mar 2016
10% owner
Bought
1,052,631
$3.00M
13.3%
ARDX ARDELYX, INC.
13 Jan 2016
10% owner
Bought
500,000
$5.00M
35.7%
ARDX ARDELYX, INC.
13 Jan 2016
10% owner
Bought
500,000
$5.00M
35.7%
ARDX ARDELYX, INC.
13 Jan 2016
10% owner
Bought
500,000
$5.00M
6.7%
CBIO CRESCENT BIOPHARMA, INC.
16 Nov 2015
10% owner
Sold, plan not stated
452
$3.12K
0.0%
SUPN SUPERNUS PHARMACEUTICALS, INC.
17 Jun 2015
10% owner
Bought
63,085
$1.05M
opened
SUPN SUPERNUS PHARMACEUTICALS, INC.
17 Jun 2015
10% owner
Sold, plan not stated
48,796
$781.80K
100%
SUPN SUPERNUS PHARMACEUTICALS, INC.
16 Jun 2015
10% owner
Sold, plan not stated
55,105
$928.67K
33.0%
ARDX ARDELYX, INC.
5 Jun 2015
10% owner
Bought
1,869,159
$20.00M
33.3%
ARDX ARDELYX, INC.
5 Jun 2015
10% owner
Bought
1,401,869
$15.00M
opened
ARDX ARDELYX, INC.
5 Jun 2015
10% owner
Bought
1,401,869
$15.00M
opened
ARDX ARDELYX, INC.
26 Dec 2014
10% owner
Sold, plan not stated
1,972
$41.96K
100%
CBIO CRESCENT BIOPHARMA, INC.
15 Jan 2014
10% owner
Bought
512,500
$4.10M
14.3%
CBIO CRESCENT BIOPHARMA, INC.
15 Jan 2014
10% owner
Bought
487,500
$3.90M
12.2%
GYRE GYRE THERAPEUTICS, INC.
5 Dec 2013
10% owner
Sold, plan not stated
1,000
$5.13K
100%
GYRE GYRE THERAPEUTICS, INC.
21 Nov 2013
10% owner
Sold, plan not stated
5,333
$27.53K
84.2%
GRPN Groupon, Inc.
18 Nov 2013
Director
Sold, plan not stated
41,260
$433.82K
100%
GRPN Groupon, Inc.
15 Aug 2013
Director
Sold, plan not stated
27,595
$269.63K
100%
43 decisions on file.